Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Thursday. The firm set a “hold” rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Milestone Scientific Price Performance

Shares of MLSS opened at $0.80 on Thursday. The firm has a market capitalization of $62.06 million, a P/E ratio of -11.86 and a beta of 1.10. Milestone Scientific has a one year low of $0.52 and a one year high of $1.10. The business has a fifty day moving average of $0.82 and a 200 day moving average of $0.85.

Insider Transactions at Milestone Scientific

In other news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the transaction, the director now owns 4,606,882 shares of the company’s stock, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have sold 109,193 shares of company stock worth $101,634 in the last 90 days. 24.75% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in MLSS. Y Intercept Hong Kong Ltd purchased a new position in shares of Milestone Scientific during the 3rd quarter valued at $48,000. Geode Capital Management LLC raised its holdings in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after acquiring an additional 31,572 shares during the period. Finally, World Investment Advisors LLC purchased a new position in shares of Milestone Scientific in the third quarter valued at about $91,000. 5.79% of the stock is currently owned by institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.